adc drug to antibody ratio (dar) - sepax technologies, … · adc drug to antibody ratio (dar) hic...
TRANSCRIPT
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc. 1
ADC Drug to Antibody Ratio (DAR)
HIC
Proteomix RP
2 www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
• Proteomix HICBu NP5, 4.6x35mm, P/N: 431NP5-4603
(polymer based)
• BioHIC 100A, 3um, 4.6x100mm, P/N: 313100-4610 (silica based)
• BioHIC 300A, 3um, 4.6x100mm, P/N: 313300-4610 (silica based)
Sepax HIC HIC hydrophobic interaction separation
min 0 2.5 5 7.5 10 12.5 15 17.5 20 22.5
mAU
0
200
400
600
800
1000
1200
3 www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® HICBu-NP5 (5 mm, 4.6 x 35 mm, Development lot) Mobile phase: A: 2 M ammonium sulfate in 0.025 M sodium phosphate, pH 7.0, B: 0.025 M sodium phosphate pH 7.0, C : 100% IPA Flow rate: 0.8 mL/min, Detector: UV 214 nm, Column temperature: 25 ℃ Sample: Herceptin/ADC1/ADC2, 1 mg/mL in 25 mM sodium phosphate, Injection: 10 mL,
T (min)
%B %C
0 25 0
15 75 25
20 75 25
21 25 0
31 25 0
Herceptin
Cysteine ADC 1
Herceptin and its ADCs separation on Proteomix ® HIC
Cysteine ADC 2
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc. 4
Proteomix® RP-1000 • With the high cross-linking structure, Proteomix® RP-1000 resins
provide excellent chemical and physical stability, as well as high rigidity to tolerate high pressure, high temperature (80 degrees).
• MAb Herceptin and its corresponding ADCs are successfully separated on the Proteomix® RP-1000, 5um, 4.6x100mm with protein peaks indicating different hydrophobicity with minimum sample carry over. Ideal tool for DAR caculation.
• Proteomix® RP-1000, 5um 2.1x50mm or 4.6x50mm provides high throughput and fast analysis of mAb, ADC and other protein therapeutics with online mass spec determination capability.
MAb Herceptin and its ADCs Separation- 4.6 x 100 mm
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 4.6 x 100 mm); Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN; Flow rate: 1.0 mL/min; Detector: UV 210 nm; Column temperature: 80 °C; Sample: Herceptin and ADCs 1 mg/mL diluted in water; Injection volume: 10 mL
5
min 2.5 5 7.5 10 12.5 15 17.5 20 22.5
mAU
175
200
225
250
275
300
325
350
375
400
Herceptin
Cysteine ADC 1 cleavable linker
Cysteine ADC 2 non-cleavable linker
Gradient: 2-22 min, 30-48%B
Herceptin/ADC1/ADC2 Separation- small size 2.1 x 50 mm
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 2.1 x 50 mm) Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN; Flow rate: 0.6 mL/min; Detector: UV 210 nm; Column temperature: 80 ˚C; Column pressure: 70 bar; Sample: Herceptin, ADC 1 and ADC 2 diluted in water; Injection volume: 0.5 mL for Herceptin, 1 mL for ADC 1 and ADC 2
min 1 2 3 4 5 6
mAU
100
150
200
250
300
Herceptin
Herceptin-ADC1
Herceptin-ADC2
Unconjugated mAb
0-5 min, 34-51% B
6
Minimum sample carry over
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 4.6 x 100 mm); Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN; Flow rate: 1.0 mL/min; Detector: UV 210 nm; Column temperature: 80 °C; Sample: Cysteine ADC 1 1 mg/mL diluted in water; Injection volume: 8 mL
7
min 2.5 5 7.5 10 12.5 15 17.5 20 22.5
mAU
180
200
220
240
260
280
300
320 2-22 min, 30-48%B
Blank
ADC
Minimum sample carry over in the blank injection after sample run.
Herceptin and its lysine ADC separation
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 4.6 x 100 mm); Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN; Flow rate: 1.0 mL/min; Detector: UV 210 nm; Column temperature: 80 °C; Sample: Herceptin and lysine ADC 1 mg/mL diluted in 0.1% TFA; Injection volume: 10 mL
8
min 0 2.5 5 7.5 10 12.5 15 17.5 20
mAU
20
40
60
80
100
Lysine-ADC
Herceptin
2-22 min, 25-55% B Each in full scale
Unconjugated mAb
MAb/ADC fragments: Reduced mAb Herceptin and Cysteine ADC 1
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 4.6 x 100 mm); Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN; Flow rate: 1.0 mL/min; Detector: UV 210 nm; Column temperature: 80 °C; Sample: Herceptin and ADC1 2 mg/mL reduced with 20 mM DTT, incubated at 65 °C for 20 minute; Injection volume: Reduced herceptin 2 mL , Reduced herceptin ADC 1 5 mL
9
min 2.5 5 7.5 10 12.5 15 17.5 20 22.5
mAU
180
200
220
240
260
280
300
320
Gradient: 2-22 min, 30-48% B
Reduced Herceptin
L0
H0
Reduced ADC 1
Possible subunits for reduced ADC: L0,L1, H0, H1, H2, H3
Mab fragment: Fab/Fc separation with 40 ˚C and 80 ˚C
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 4.6 x 100 mm); Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN; Flow rate: 1.0 mL/min; Detector: UV 210 nm; Column temperature: 40, 80 ˚C; Sample: mAb (digested by papain), 1 mg/mL diluted in 0.1% TFA; Injection volume: 20 mL
10
min 2.5 5 7.5 10 12.5 15 17.5 20 22.5
mAU
200
250
300
350
400
450
40 ˚C
80 ˚C
2-22 min, 30-40% B
Temperature effect: mAb separation with 25°C /40°C / 80°C
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 4.6 x 100 mm); Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN Flow rate: 1.0 mL/min; Detector: UV 210 nm; Sample: mAb 1mg/mL; Injection volume: 20 mL
11
min 2.5 5 7.5 10 12.5 15 17.5 20 22.5
mAU
250
500
750
1000
1250
1500
1750
2000
2250
40 °C
80 °C
25 °C
min 6 8 10 12 14 16
mAU
0
20
40
60
80
100
120
140
160
2-22 min, 20-70%
Temperature effect: Herceptin Cysteine ADC 2 Separation
www.sepax-tech.com
Better Surface Chemistry for Better Separation © Sepax Technologies, Inc.
Column: Proteomix® RP-1000 (5 µm, 1000 Å, 4.6 x 100 mm); Mobile phase: A: 0.1% TFA in water; B: 0.1% TFA in 100% ACN; Flow rate: 1.0 mL/min; Detector: UV 210 nm; Column temperature: 25, 80 ˚C; Sample: Herceptin Cysteine ADC 2 1 mg/mL diluted in 0.1% TFA; Injection volume: 20 mL
12
min 0 2.5 5 7.5 10 12.5 15 17.5 20 22.5
mAU
100
200
300
400
500
600
700
80 ˚C
25 ˚C
2-22 min, 20-70%